so I think I will head into prompt care to at least get a blood test or some reassurance or documentation or something....
http://www.stevens-johnson-syndrome-lawyer.com/lamictal.htmlFor too many, the warnings concerning Lamictal have come too late.
Lamictal has been linked with serious risk of Stevens-Johnson Syndrome, and potentially life-threatening conditions known as erythema multiforme and toxic epidermal necrolysis. The symptoms of these life-threatening drug reactions include rash, blisters, or red splotches on skin, persistent fever, and blisters in the mouth, eyes, ears, nose and genital area. If left untreated, these conditions can result in death.
and more
looks like I have hypersensitivity to
anticonvulsants-which is genetic
herpes connection is noted in info below footnote 8
includes lamictal if you scroll down to table 3 at link
http://www.residentandstaff.com/issues/articles/2007-03_11.aspIssue: March 2007 • Vol 53 • No 3
Anticonvulsant Hypersensitivity Syndrome: Recognizing
the Signs and Symptoms
Marcus E.S. Mason, MD, FCCWS
Attending Physician
Internal and Geriatric Medicine
University of Miami/Jackson Memorial & Miami Veterans
Administration Hospitals
Miami, Fla
Anticonvulsant hypersensitivity syndrome is an
uncommon but potentially fatal condition that can
occur in susceptible patients taking one of the
aromatic anticonvulsants, such as phenytoin,
carbamazepine, or phenobarbital. Signs and symptoms
typically include high fever, rash, lymphadenopathy,
and hematologic abnormalities. Elevated fever and skin
rash that cannot be explained by other causes should
alert the physician to the possibility of this
syndrome in patients taking an anticonvulsant
medication. Immediate discontinuation of the offending
agent is necessary; early recognition can prevent
permanent multiorgan damage.
Anticonvulsant hypersensitivity syndrome—also known as
phenytoin pseudolymphoma syndrome—is a potentially
fatal idiosyncratic drug reaction to certain
anticonvulsant medications that break down into
intermediate metabolites, specifically arene oxides.
Responsible medications include phenytoin (Dilantin,
Phenytek), carbamazepine (Carbatrol, Epitol,
Tegretol), oxcarbazepine (Trileptal), and
phenobarbital sodium (Table 1). The cross-reactivity
of these drugs ranges from 50% to 80%.1,2
Recent research suggests there may be a genetic
component (possibly autosomal) that contributes to
susceptibility, since siblings and other first-degree
relatives of affected patients appear to be at
increased risk.
3 These individuals may have a genetic inability to
detoxify the arene oxide, because of an absence, low
concentration, or diminished activity of the enzyme
epoxide hydrolase. This would allow the antiepileptic
and its oxidized metabolites to accumulate, possibly
activating cytokines and T cells through the major
histocompatibility and other pathways.
7 This T-cell–mediated chemotoxic reaction occurs in
areas that contain cytochrome oxidase, such as the
liver, lungs, skin, and mucosa, often affected organs
that contain the CYP-450 enzyme and epoxide hydrolase.
6 One study suggested an association between a
cutaneous reaction to carbamazepine and the presence
of the HLA-B*1502 gene in certain patients.
8 Additional reports have shown a relationship between
the hypersensitivity syndrome and reactivation of
herpesvirus 6 and 7.9,10 Other factors that may
contribute to anticonvulsant hypersensitivity syndrome
are allergic hypersensitivity and a form of
graft-versus-host disease.